Technetium-99m-tetrofosmin single-photon emission computed tomography at rest is practical for routine assessment of viability in patients with ischemic cardiomyopathy. However, underestimation of viability may occur compared with 18F-fluorodeoxyglucose single-photon emission computed tomography, especially in the inferoposterior and septal regions.

doi.org/10.1016/j.amjcard.2005.01.050, hdl.handle.net/1765/55933
The American Journal of Cardiology
Department of Cardiology

Schinkel, A., Poldermans, D., Bax, J., Biagini, E., Elhendy, A., van Domburg, R., … Simoons, M. (2005). Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability. The American Journal of Cardiology, 95(10), 1223–1225. doi:10.1016/j.amjcard.2005.01.050